Phase II Clofarabine and Cytarabine for Newly Diagnosed Acute Myeloid Leukemia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The combination of clofarabine and cytarabine is an effective and reasonably well-tolerated treatment regimen in patients with either relapsed/refractory or newly diagnosed AML. For this prospective study, we propose the use of clofarabine and cytarabine for second course induction therapy for patients with persistent AML after treatment with an anthracycline and cytarabine.
Epistemonikos ID: 340bc123844ce210b04ee32cb51bb072d0e9dfbf
First added on: May 11, 2024